Sophie Dupont
Overview
Explore the profile of Sophie Dupont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
2079
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dupont S
Epilepsy Behav
. 2025 Jan;
164:110266.
PMID: 39826184
This narrative review aims to identify and summarize existing research to better understand the pathophysiological and neuroanatomical bases of social cognition deficits in people with epilepsy. The neuroanatomical basis of...
2.
Delion T, Jacquemont T, Daghsen L, Valabregue R, Beanato E, Hummel F, et al.
Cerebellum
. 2025 Jan;
24(1):28.
PMID: 39786475
Cerebellar functional and structural connectivity are likely related to motor function after stroke. Less is known about motor recovery, which is defined as a gain of function between two time...
3.
4.
Dupont S
Rev Prat
. 2024 Dec;
74(9):996-1000.
PMID: 39625027
IMPACT OF EPILEPSY ON PERSONAL AND PROFESSIONAL LIFE. Epilepsy is more than the occurrence of seizures and their direct consequences. Epilepsy is a chronic, often ostracizing disease, which has repercussions...
5.
Dupont S
Rev Prat
. 2024 Dec;
74(9):981-984.
PMID: 39625024
MANAGING AND PLANNING PREGNANCY IN PATIENTS WITH EPILEPSY. Managing the pregnancy of a patient with epilepsy involves multidisciplinary management and pregnancy planning. Thanks to pregnancy registries, the impact of certain...
6.
Dupont S
Rev Prat
. 2024 Dec;
74(9):958-962.
PMID: 39625019
EPILEPSY DEFINITIONS, CLASSIFICATIONS AND EPIDEMIOLOGY. Epilepsy is the most common neurological disease in the world and the second most common in France. It is defined by the occurrence of 2...
7.
Calonge Q, Besnard A, Bailly L, Damiano M, Pichit P, Dupont S, et al.
Brain Behav
. 2024 Nov;
14(11):e70122.
PMID: 39501537
Background And Purpose: Around 30% of patients with epilepsy show drug-resistant epilepsy (DRE). While cannabidiol has demonstrated efficacy as an adjunctive treatment in Dravet syndrome (DS), Lennox-Gastaut Syndrome (LGS), and...
8.
Aboubakr O, Houillier C, Alentorn A, Choquet S, Dupont S, Mokhtari K, et al.
Neurology
. 2024 Aug;
103(5):e209748.
PMID: 39116374
Background And Objectives: Epilepsy is a common comorbidity of brain tumors; however, little is known about the prevalence, onset time, semiology, and risk factors of seizures in primary CNS lymphoma...
9.
Garvayo M, Dupont S, Frazzini V, Bielle F, Adam C, Bendary Y, et al.
J Neurol
. 2024 Jul;
271(9):6197-6208.
PMID: 39069564
Background: Mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE/HS) is the most common cause of drug-resistant focal seizures and surgical resection is the primary treatment option, with seizure-free rates...
10.
Salleles E, Samson S, Denos M, Mere M, Lehericy S, Herlin B, et al.
Epilepsy Res
. 2024 Jul;
205:107405.
PMID: 39002388
In medial temporal lobe epilepsy (MTLE), the benefits of surgery must be balanced against the risk of post-operative memory decline. Prediction of postoperative outcomes based on functional magnetic resonance imaging...